129 related articles for article (PubMed ID: 32614460)
1. Synergistic effects of extracellular vesicle phenotyping and AFP in hepatobiliary cancer differentiation.
Urban SK; Sänger H; Krawczyk M; Julich-Haertel H; Willms A; Ligocka J; Azkargorta M; Mocan T; Kahlert C; Kruk B; Jankowski K; Patkowski W; Krawczyk M; Zieniewicz K; Hołówko W; Krupa Ł; Rzucidło M; Gutkowski K; Wystrychowski W; Król R; Raszeja-Wyszomirska J; Słomka A; Schwab R; Wöhler A; Gonzalez-Carmona MA; Gehlert S; Sparchez Z; Banales JM; Strassburg CP; Lammert F; Milkiewicz P; Kornek M
Liver Int; 2020 Dec; 40(12):3103-3116. PubMed ID: 32614460
[TBL] [Abstract][Full Text] [Related]
2. Cancer-associated circulating large extracellular vesicles in cholangiocarcinoma and hepatocellular carcinoma.
Julich-Haertel H; Urban SK; Krawczyk M; Willms A; Jankowski K; Patkowski W; Kruk B; Krasnodębski M; Ligocka J; Schwab R; Richardsen I; Schaaf S; Klein A; Gehlert S; Sänger H; Casper M; Banales JM; Schuppan D; Milkiewicz P; Lammert F; Krawczyk M; Lukacs-Kornek V; Kornek M
J Hepatol; 2017 Aug; 67(2):282-292. PubMed ID: 28267620
[TBL] [Abstract][Full Text] [Related]
3. Extracellular mRNA detected by molecular beacons in tethered lipoplex nanoparticles for diagnosis of human hepatocellular carcinoma.
Wang X; Kwak KJ; Yang Z; Zhang A; Zhang X; Sullivan R; Lin D; Lee RL; Castro C; Ghoshal K; Schmidt C; Lee LJ
PLoS One; 2018; 13(6):e0198552. PubMed ID: 29879168
[TBL] [Abstract][Full Text] [Related]
4. PIVKA-II serves as a potential biomarker that complements AFP for the diagnosis of hepatocellular carcinoma.
Feng H; Li B; Li Z; Wei Q; Ren L
BMC Cancer; 2021 Apr; 21(1):401. PubMed ID: 33849479
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic role of serum glypican-3 in differentiating hepatocellular carcinoma from non-malignant chronic liver disease and other liver cancers.
Tangkijvanich P; Chanmee T; Komtong S; Mahachai V; Wisedopas N; Pothacharoen P; Kongtawelert P
J Gastroenterol Hepatol; 2010 Jan; 25(1):129-37. PubMed ID: 19793164
[TBL] [Abstract][Full Text] [Related]
6. Extracellular vesicles as potential biomarkers for diagnosis and recurrence detection of hepatocellular carcinoma.
Juratli MA; Pollmann NS; Oppermann E; Mohr A; Roy D; Schnitzbauer A; Michalik S; Vogl T; Stoecklein NH; Houben P; Katou S; Becker F; Hoelzen JP; Andreou A; Pascher A; Bechstein WO; Struecker B
Sci Rep; 2024 Mar; 14(1):5322. PubMed ID: 38438456
[TBL] [Abstract][Full Text] [Related]
7. Tumour markers in diagnosis and management.
Warnes TW; Smith A
Baillieres Clin Gastroenterol; 1987 Jan; 1(1):63-89. PubMed ID: 2437983
[TBL] [Abstract][Full Text] [Related]
8. Extracellular vesicles as a new hope for diagnosis and therapeutic intervention for hepatocellular carcinoma.
Nimitrungtawee N; Inmutto N; Chattipakorn SC; Chattipakorn N
Cancer Med; 2021 Dec; 10(23):8253-8271. PubMed ID: 34708589
[TBL] [Abstract][Full Text] [Related]
9. Combination of inflammatory score/liver function and AFP improves the diagnostic accuracy of HBV-related hepatocellular carcinoma.
Ding Y; Liu K; Xu Y; Zhao Q; Lou S; Xiang X; Yan L; Cao Z; Xie Q; Zhu C; Bao S; Wang H
Cancer Med; 2020 May; 9(9):3057-3069. PubMed ID: 32150664
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic value of serum PIVKA-II levels for BCLC early hepatocellular carcinoma and correlation with HBV DNA.
Wu J; Xiang Z; Bai L; He L; Tan L; Hu M; Ren Y
Cancer Biomark; 2018; 23(2):235-242. PubMed ID: 30103302
[TBL] [Abstract][Full Text] [Related]
11. TEMs but not DKK1 could serve as complementary biomarkers for AFP in diagnosing AFP-negative hepatocellular carcinoma.
Mao L; Wang Y; Wang D; Han G; Fu S; Wang J
PLoS One; 2017; 12(9):e0183880. PubMed ID: 28902891
[TBL] [Abstract][Full Text] [Related]
12. Potential diagnostic performance of contrast-enhanced ultrasound and tumor markers in differentiating combined hepatocellular-cholangiocarcinoma from hepatocellular carcinoma and cholangiocarcinoma.
Huang XW; Huang Y; Chen LD; Wang Z; Yang Z; Liu JY; Xie XY; Lu MD; Shen SL; Wang W
J Med Ultrason (2001); 2018 Apr; 45(2):231-241. PubMed ID: 29052791
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic value of serum glypican-3 alone and in combination with AFP as an aid in the diagnosis of liver cancer.
Liu S; Wang M; Zheng C; Zhong Q; Shi Y; Han X
Clin Biochem; 2020 May; 79():54-60. PubMed ID: 32087138
[TBL] [Abstract][Full Text] [Related]
14. Application of classification tree and neural network algorithms to the identification of serological liver marker profiles for the diagnosis of hepatocellular carcinoma.
Poon TC; Chan AT; Zee B; Ho SK; Mok TS; Leung TW; Johnson PJ
Oncology; 2001; 61(4):275-83. PubMed ID: 11721174
[TBL] [Abstract][Full Text] [Related]
15. Current Status and Perspective Biomarkers in AFP Negative HCC: Towards Screening for and Diagnosing Hepatocellular Carcinoma at an Earlier Stage.
Luo P; Wu S; Yu Y; Ming X; Li S; Zuo X; Tu J
Pathol Oncol Res; 2020 Apr; 26(2):599-603. PubMed ID: 30661224
[TBL] [Abstract][Full Text] [Related]
16. Human telomerase reverse transcriptase messenger RNA (TERT mRNA) as a tumour marker for early detection of hepatocellular carcinoma.
El-Mazny A; Sayed M; Sharaf S
Arab J Gastroenterol; 2014 Jun; 15(2):68-71. PubMed ID: 25097049
[TBL] [Abstract][Full Text] [Related]
17. [The value of serum abnormal prothrombin in clinical application of hepatocellular carcinoma].
Zhang JW; Guan LY; E CY; Yang JH; Xuan W; Meng ZH; Li W
Zhonghua Wai Ke Za Zhi; 2020 Oct; 58(10):776-781. PubMed ID: 32993265
[No Abstract] [Full Text] [Related]
18. Tumour-associated circulating microparticles: A novel liquid biopsy tool for screening and therapy monitoring of colorectal carcinoma and other epithelial neoplasia.
Willms A; Müller C; Julich H; Klein N; Schwab R; Güsgen C; Richardsen I; Schaaf S; Krawczyk M; Krawczyk M; Lammert F; Schuppan D; Lukacs-Kornek V; Kornek M
Oncotarget; 2016 May; 7(21):30867-75. PubMed ID: 27127176
[TBL] [Abstract][Full Text] [Related]
19. The role of tumor markers in the diagnosis of hepatocellular carcinoma, with special reference to the des-gamma-carboxy prothrombin.
Grazi GL; Mazziotti A; Legnani C; Jovine E; Miniero R; Gallucci A; Palareti G; Gozzetti G
Liver Transpl Surg; 1995 Jul; 1(4):249-55. PubMed ID: 9346575
[TBL] [Abstract][Full Text] [Related]
20. [Application of alpha-fetoprotein in the diagnosis of hepatocellular carcinoma].
Jia HL; Xing XJ; Ye QH; Qin LX
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2008 Aug; 30(4):440-3. PubMed ID: 18795617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
